News

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight.
She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist ...
A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.
Patients with type 2 diabetes had a lower risk of glaucoma when they used glucagon-like peptide 1 (GLP-1) receptor agonists across multiple studies.
The companies are working together to make it easier for companies to offer health plans that include these medications.
Revolutionizing Access to Modern Weight-Care SolutionsSan Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, ...
In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.
A study presented at the American Society for Metabolic and Bariatric Surgery highlighted that bariatric surgeries, ...